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Physalis minima L. is reputed for having anticancer property. In this study, the chloroform extract of this plant exhibited remarkable
cytotoxic activities on NCI-H23 (human lung adenocarcinoma) cell line at dose- and time-dependent manners (after 24, 48 and
72 h of incubation). Analysis of cell-death mechanism demonstrated that the extract exerted apoptotic programed cell death
in NCI-H23 cells with typical DNA fragmentation, which is a biochemical hallmark of apoptosis. Morphological observation
using transmission electron microscope (TEM) also displayed apoptotic characteristics in the treated cells, including clumping
and margination of chromatins, followed by convolution of the nuclear and budding of the cells to produce membrane-bound
apoptotic bodies. Diﬀerent stages of apoptotic programed cell death as well as phosphatidylserine externalization were confirmed
using annexin V and propidium iodide staining. Furthermore, acute exposure to the extract produced a significant regulation of
c-myc, caspase-3 and p53 mRNA expression in this cell line. Due to its apoptotic eﬀect on NCI-H23 cells, it is strongly suggested
that the extract could be further developed as an anticancer drug.
1. Introduction
Lung cancer remains a major global health problem,
accounting for more than a million annual deaths worldwide
[1]. It is twice the death rate of the second-most prevalent
cancer, that is, prostate cancer in men [2]. The incidence of
lung cancer can be correlated with the age of both males and
females and there is still lack of eﬀective drugs to treat this
disease [3].
Herbal formulation consisting of single and multiple of
herbs is commonly prescribed as an alternative way to treat
cancer. An anticancer plant that was selected for this study
is Physalis minima L. The decoction of the whole plant is
taken orally to treat cancer and the leaves are used as a
poultice for ulcer [4, 5]. This herb is commonly known as the
bladder cherry (Leletup-direct translation from Malay) and
belongs to the Solanaceae family [5]. Its reputed eﬃcacy in
treating cancer has been validated (in vitro) against CORL23
lung and MCF7 breast cancer cell lines, but the mechanisms
underlying the anticancer activity still remain unknown.
Two active anticancer compounds have been isolated from
its methanol extract of stem and leaf and were identified
as physalin B and physalin F [6]. However, these two
compounds were found to exhibit non-selective cytoxicity
against all tested human cell lines including non-cancerous
cell with physalin F consistently more active [6, 7].
Recently, intensive studies have been conducted to exam-
ine the mechanism responsible for the anticancer eﬀects
of plant-based drugs. Apoptosis is a specific mode of cell
death that can only target cancer cell with little or no
damage to non-cancerous cells [8]. It helps in reducing
the incidence of side eﬀect in patients [9]. Information on
the apoptotic eﬀect elicited by the extracts and bioactive
compounds of Physalis sp. are still limited to a few findings,
such as the cell death signaling eﬀects of physalins B and
F on PANC-1 pancreatic cancer cells. They were reported
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as potent inhibitors for the aberrant hedgehog (Hh)/GLI
signaling pathway (that causes formation and progression of
various cancers) by inhibiting GL2-mediated transcriptional
activation, decreasing hedgehog-related component expres-
sion and reducing the level of anti-apoptotic Bcl-2 gene
expression [10]. Moreover, apoptotic induction in human
lung cancer H661 cells by the supercritical carbon dioxide
extract of Physalis peruviana was associated with cell cycle
arrest at the S phase, mediated through the p53-dependent
pathway and modification of pro-apoptotic protein (Bax)
and inhibitor of apoptosis protein (IAP) expression [11].
In addition, the ethanol extract of P. peruviana was found
to induce apoptosis on human liver cancer Hep G2 cells
through CD95/CD95L system and the mitochondrial signal-
ing transduction pathway [12]. Furthermore, the methanol
extract of Physalis angulata induced apoptosis and arrested
human breast cancer MAD-MB 231 cells at G2/M phase
[13] and induced apoptosis in human oral cancer HSC-3
cells through oxidative stress-dependent induction of protein
expression such as heme oxygenase-1 and Cu/Zn superoxide
dismutase [14].
Based on our previous comparative cytotoxicity studies
of the extracts and fractions (obtained from the chloroform
extract) of Physalis minima, it has been established that the
anti-proliferative activity of the chloroform extract in human
lung adenocarcinoma NCI-H23 cells was relatively better
than other extracts and its fractions [15]. Therefore, it was
selected for this study with aims (i) to evaluate the eﬀect
of the extract to NCI-H23 cells proliferation in diﬀerent
incubation periods and (ii) to determine the cell death
mechanism elicited by the extract via morphological and
molecular investigations.
2. Methods
2.1. Chemicals. The DeadEnd Colometric Apoptosis Detec-
tion System was purchased from Promega, USA. The
Annexin-V-FLOUS kit was purchased from Roche Diagnos-
tics, Germany. The methylene blue assay, dimethyl sulfoxide
(DMSO) and propidium iodide were obtained from Sigma
Aldrich, USA. All culture media and additives were from
Hyclone, USA. All other chemicals were reagents of molec-
ular grade, as appropriate.
2.2. Preparation of Crude Extracts. The P. minima plant
was collected from Arau-Perlis, Malaysia. The plant was
identified and verified by Mr V. Shunmugam of Universiti
Sains Malaysia. The voucher specimen (no. 11001) was
preserved and deposited in the herbarium of School of
Biological Sciences, Universiti Sains Malaysia.
The whole plant materials were washed, dried and
chopped finely using a grinder. The dried material was then
transferred into the Soxhlet extractor. The dried plant mate-
rial was exhaustively extracted with chloroform by Soxhlet
extraction. The extracts were filtered and concentrated using
rotary evaporator, and then evaporated to dryness. The dried
extracts were then weighed using microbalances (Sartorius,
Germany) and reconstituted with 99.9% (v/v) DMSO to
prepare a stock solution at a concentration of 10 mg/mL. The
stock solution was serially diluted to eight diﬀerent working
concentrations. As for the positive control, the stock solution
of vincristine sulfate (a commercial drug) at a concentration
of 1 mg/mL was prepared using DMSO and diluted serially
to 24 diﬀerent concentrations.
2.3. Cell Line and Culture Medium. NCI-H23 (human lung
adenocarcinoma) cell line was obtained from American
Type Cell Culture (ATCC), USA, and cultured in RPMI
1640, supplemented with 2 mM l-glutamine, 10% (v/v)
fetal calf serum (FCS), 100 U/mL penicillin and 100 μg/mL
streptomycin, as recommended by ATCC.
2.4. In Vitro Cytotoxicity Assay. Nearly confluent cultures
of cells were harvested with 0.05% (w/v) Trypsin-EDTA.
Cells were then centrifuged and pellet resuspended with a
complete medium with 10% (v/v) FCS. Then, 100 μL of
cells were plated into each well of 96-well plate at a density
of ∼6000 cells/well. Cell viability was routinely determined
using the trypan blue exclusion test to ensure it was always
in excess of 95%. The cells were then allowed to attach
and incubate at 37◦C in a CO2 incubator for a further
24–48 h. After the cells reached 80–90% confluence, the
medium was removed and replaced with medium containing
only 0.5% (v/v) FCS and the cells were incubated for
further 4 h. The reason for this was for the cells to achieve
quiescent. Subsequently, the cells were treated with diﬀerent
concentrations of extracts. Controlled cells were cultured in
a 0.5% (v/v) FCS-containing medium alone. Of serial diluted
extracts, 1 μL was added into each well. After treatment, the
plates were incubated for 72 h. Vincristine sulfate was used as
a positive control.
Cell survival was determined by the procedure using
methylene blue staining as described by Yamazaki et al.
[16] and Li and Hwang [17]. After 72 h of incubation with
plant extracts, the surviving cells were fixed with 2.5%
(v/v) glutaraldehyde for 15 min and were then washed with
a 0.15 M sodium chloride (NaCl) solution to remove the
dead cells. The fixer cells subsequently were stained with
100 μL of 0.05% (w/v) methylene blue solution for 15 min.
After washing oﬀ the excess dye with NaCl, dye elution
was carried out using 200 μL of 0.33 M hydrochloric acid
(HCl). Absorbance was read at 650 nm using Vmax Kinetic
Microplate Reader (Molecular Devices, USA). The number
of surviving cells was determined from the absorbance value.
2.5. Detection of DNA Fragmentation. Nuclear DNA frag-
mentation was detected using DeadEnd Colometric Apop-
tosis Detection System (Promega, USA). Briefly, cell suspen-
sions were subcultured on Labtek Chamber Slides, and then
incubated for 24–48 h. When the cells achieved confluency
between 80% and 90%, the medium was replaced with a
medium containing only 0.5% (v/v) FCS. The cells were
then incubated at 37◦C for 4 h and treated with the P.
minima chloroform extract at a concentration of EC50 at
72 h (2.80 μg/mL). Negative control cells were treated with
the same concentration of DMSO. Positive control cells
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were treated with DNase I (1 U/mL) and vincristine sulfate
at a concentration of EC50 at 72 h (0.0015 μg/mL). In all
cases, the final concentration of DMSO in each control slide
did not exceed 1% (v/v). The slides were then incubated
for 24 h. After treatment, the cells were rinsed twice with
a phosphate-buﬀered saline (PBS), and then processed
according to the DeadEnd Colometric Apoptosis Detection
System protocol as described by the manufacturer (Promega,
USA). Subsequently, the slides were observed using the
light microscope (Olympus BH2 light microscope) and the
images taken using the AnalySIS Docu SoftImaging Software,
Germany.
2.6. Detection of Plasma Membrane Integrity. In order to
detect the loss of plasma membrane of necrotic cells, the
NCI-H23 cells were cultured on 6-well plates, and then
incubated for 24–48 h. When the cells reached between 80%
and 90% confluency, the medium was replaced with a fresh
medium containing only 0.5% (v/v) FCS. The cells were
then incubated for a further 4 h and treated with the P.
minima chloroform extract at a concentration of EC50 at
72 h (2.80 μg/mL). Negative control cells were treated with
the same concentration of DMSO. The cells were rinsed with
PBS and stained using the trypan blue exclusion assay after 24
and 72 h incubation period. Subsequently, the samples were
viewed using an inverted phase contrast light microscope.
2.7. Ultrastructural Analysis. NCI-H23 cells were incubated
with the P. minima chloroform extract at a concentration
of EC50 at 72 h (2.80 μg/mL) for 24 h. Negative control cells
were treated with the similar concentration of DMSO. After
incubation, the cells were trypsinized, centrifuged and then
resuspended twice with PBS. The cells were then rinsed,
pelleted and then resuspended in the McDowell-Trump
fixative solution [containing 4% (v/v) formaldehyde and
1% (v/v) glutaraldehyde in a 0.1 M phosphate buﬀer, pH
7.3] at 4◦C for 24 h. The cells were pelleted and rinsed
in a 0.1 M phosphate buﬀer for 10 min and repeated three
times. Post-fixed was carried out with 1% (w/v) osmium
tetroxide prepared in a 0.1 M phosphate buﬀer for 1-2 h at
room temperature. The cells were then dehydrated with 50%
(v/v) ethanol for 15 min, followed by 75% (v/v) ethanol for
15 min, 95% (v/v) ethanol for 15 min and repeated, 100%
(v/v) ethanol for 30 min and repeated and, lastly, 100% (v/v)
acetone for 10 min and repeated. Infiltration was conducted
using the mixture of acetone : Spurr’s resin mix (1 : 1) in a
rotator for another 2-3 days with a daily change of Spurr’s
mix of each sample specimen. Subsequently, the cells were
embedded and cured at 60◦C for 12–48 h.
Sectioning was preceded by the analysis of a semi-thin
section (1 μm), stained at 40◦C with 1% (w/v) toluidine
blue. This was then followed by sectioning of thin sections
(<1 μm), collected using copper grids. Reichart Supernova
Ultra Microtome was used to produce the sections. The
thin sections were stained with uranyl acetate for 15 min
by complete immersion, in a covered Petri-dish lined with
dental wax. Lastly, the sections were stained with lead citrate
using the same procedures. The samples were examined
and observed under a Philips CM 12 transmission electron
microscope (TEM).
2.8. Detection of Phosphatidylserine Externalization. NCI-
H23 cells were incubated with the P. minima chloroform
extract at a concentration of EC50 at 72 h (2.80 μg/mL)
for 24 h. Negative control cells were treated with the
similar concentration of DMSO. After treatment, the cell
in the chamber slides were washed with PBS twice and
subsequently processed according to the Annexin-V-FLUOS
(Roche Diagnostics, Germany) (combination of annexin
V and propidium iodide) protocol as described by the
manufacturer’s instruction. Subsequently, the slides were
immediately analyzed using a fluorescence microscope with
an excitation wavelength in the range of 450–500 nm and
detection in the range of 515–565 nm (green). Photos were
taken using the Olympus BH2-RFCA Fluorescence Micro-
scope with Olympus camera attachment. Green fluorescence
was observed in annexin V positive cells and red fluorescence
in cells which uptake the propidium iodide dye.
2.9. Determination of Apoptotic-Related Genes Expression.
In order to investigate the mRNA expression levels of c-
myc, caspase-3 and p53, which are responsible to trigger
apoptosis mechanism, semi-quantitative reverse transcrip-
tion polymerase chain reaction (RT-PCR) was carried out.
NCI-H23 cells were cultured in T25 flasks and starved
with a medium containing only 0.5% (v/v) FCS for 4 h.
The cells were then treated with the P. minima chloroform
extract at a concentration of EC50 at 72 h (2.80 μg/mL) for
the period of 24 h. After treatment, the total cellular RNA
was isolated using the Tri-Reagent LS (Molecular Research
Center, USA) according to the manufacturer’s instructions.
Of the isolated total cellular RNA sample, 1 μg was treated
with DNase I, followed by reverse transcribed into cDNA
and subjected to PCR amplification. The optimized PCR
amplification program comprised an initial denaturation
step at 94◦C for 2 min, followed by denaturation at 94◦C
for 45 s, annealing at 56◦C for 1 min, extension at 72◦C
for 2 min and final extension step at 72◦C for 10 min.
The PCR optimization process including the optimal cDNA
concentration and the number of amplification cycles used
to amplify c-myc, caspase-3, p53 and β-actin genes was in
the exponential phase of PCR amplification (i.e. provide a
linear relationship between the amount of amplification and
the concentration of the original cDNA temples) (data not
shown), indicating that the conditions were optimized for
semi-quantitative studies [14, 15]. The sequences of primers
for analysis were synthesized based on the human mRNA
encoding the respective genes. The amplification products
were separated on 1.2% (w/v) agarose gel and stained with
ethidium bromide. Gene expressions signaling at each point
of time were quantified using GeneTools analysis software on
GENE GENIUS gel documentation system (Syngene, UK).
The signals of c-myc, p53 and caspase-3 were normalized
from β-actin and the ratio in unstimulated samples was
assigned as 1. The housekeeping gene β-actin was used as an
internal standard control.
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2.10. Calculation and Statistics. Cytotoxicity experiments
were performed in six replicates and results were expressed
as percentage growth inhibition of control. EC50 values
for growth inhibition was derived from a nonlinear model
(curvfit) based on the sigmoidal dose response curve (vari-
able) and computed using GraphPadPrism, USA. Data are
given as mean ± SEM. The criterion of cytotoxic or non-
cytotoxic was adapted from the guidelines set by the National
Cancer Institute (NCI) which indicated that plant extracts
with EC50 ≤ 20μg/mL were considered to be cytotoxic and
non-cytotoxic if otherwise [18].
DNA fragmentation experiments were conducted in
triplicate. The cells from five random microscopic fields were
counted to get the percentage of TUNEL positive cells (apop-
totic index, AI% = number of apoptotic nuclei/number of
nuclei scored ×100%) using 200x magnifications and the
mean percentage ± SEM was calculated. The significant
diﬀerences between the mean percentage of positive stained
nuclei of control cells and treated cells were determined
using one-way ANOVA, computed using GraphPadPrism
(Graphpad, USA).
The significant diﬀerences in the ratio to β-actin
(between each time point and control) were determined
using one-way ANOVA and Dunnett’s Multiple Comparison
Test for post-comparison tests, computed using GraphPad-
Prism software (GraphPad, USA). Diﬀerences were consid-
ered to be significant if P < .05.
3. Results
3.1. Cytotoxic Eﬀect of the Chloroform Extract of P. minima
on NCI-H23 Cells. Dose-dependent inhibitions in NCI-H23
cells were observed when the cells were treated with this
extract at all incubation intervals (Figure 1). Interestingly,
the chloroform extract produced >75% of growth inhibition
in NCI-H23 cells, which appeared to be relatively unchanged
at higher concentrations (25–100 μg/mL) for all time points
(Figure 1). After 24 h of treatment, only at a concentration
of 6.25 μg/mL and above, the chloroform extract signifi-
cantly inhibited the growth of NCI-H23 cells (P < .05).
Meanwhile, after 48 and 72 h of incubation, at most tested
concentrations (100–1.563 μg/mL), the extract exhibited
significant inhibitory eﬀects (P < .05). The inhibitory
activities increased and the EC50 values decreased as the
incubation periods were increased from 24 h (5.28 μg/mL) to
48 h (3.55 μg/mL) and 72 h (2.80 μg/mL). However, the EC50
for vincristine sulfate (0.0015 μg/mL) was very much lower as
compared to the EC50 deduced from the chloroform extract
at 72 h incubation period (data not shown).
3.2. Eﬀect of P. minima Chloroform Extract on Cell Death of
NCI-H23 Cells. In order to investigate whether apoptosis
may play an important role in mediating the cell death
of NCl-H23 cells elicited by the chloroform extract of P.
minima, the fragmented genomic DNA was detected using
a modified TUNEL assay. As shown in Figures 2(b), 2(c) and
2(d), the extract-treated NCl-H23 cells produced dark brown
stained nuclei with similar observation found in the positive
72 hours48 hours24 hours
Time of incubation
100 μg/mL
50 μg/mL
25 μg/mL
12.5 μg/mL
6.25 μg/mL
3.125 μg/mL
1.563 μg/mL
0.781 μg/mL
0
25
50
75
100
G
ro
w
th
in
h
ib
it
io
n
(%
)
∗∗∗∗
∗
∗∗∗
∗
∗
∗
∗
∗∗∗∗∗
∗
∗
Figure 1: Eﬀect of P. minima chloroform extract on proliferation
of NCI-H23 cells at 24, 48 and 72 h. Each value represented mean±
SEM of six replicates (n = 6); ∗P < .05.
control cells treated with DNase I and vincristine sulfate.
The nuclei were specifically stained and evenly distributed.
Most of the positive stained nuclei were rounded or oblong
in shape. But almost all nuclei of untreated negative control
cells were not stained with this assay (Figure 2(a)). The
mean percentage of apoptotic index for the extract-treated
NCl-H23 cells was 49.89% and significantly diﬀerent as
compared to the negative control (DMSO) (1.39%) (P <
.001) (Figure 2(e). Comparatively, the percentage was lower
than that in positive controls (68.41% and 56.40% for DNase
I and vincristine sulfate, resp.). This result strongly indicated
that apoptosis was one of the possible type of cell death in
NCl-H23 cells after 24 h exposure to the chloroform extract.
The trypan blue exclusion assay showed that only a few
NCl-H23 cells were positively stained after treated with the
extract for 24 and 72 h. The results strongly suggested that
the surface of most treated cells was intact after incubation
with the extract at both time points (Figures 3(a) and 3(b).
Therefore, the mode of cell death elicited by the chloroform
extract of P. minima in NCI-H23 cells was unlikely via
necrotic mechanism in nature.
TEM analysis exhibited diﬀerent morphological alter-
ations in NCI-H23 cells after treatment with the chloroform
extract of P. minima for 24 h. Characteristics of apoptotic
cell death were observed in the majority of treated NCI-H23
cells. There was clumping of the nuclear chromatin into more
densely packed material that becomes marginated against the
nuclear membrane (Figure 4(a)). This was accompanied by
a convolution of nuclear envelope and cytoplasmic mem-
brane (Figure 4(b)). However, the cytoplasmic membrane
and cell organelles remained intact. Budding of cells was
clearly demonstrated (Figure 4(c)), where the cytoplasmic
membrane formed extensions and separated. The plasma
membrane was then sealed to produce membrane-bound
apoptotic bodies that contained cellular material of the
cells in various combinations. These ultrastructural analysis
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Figure 2: The eﬀect of (a) DMSO l% (v/v), (b) Physalis minima chloroform extract (2.80 μg/mL, EC50 a 72 h), (c) DNase I (1 U/mL) and (d)
vincrstine sulphate (0.0015 μg/mL, EC50 at 72 h) or NCI-H2: cells for 24 h and subjected to Deadend Colometric Apoptosis Detection System
(Promega, USA) Apoptotic cells with stained nuclei were rnarked by arrows. (e) Comparison of the mean percentage of apoptotic index
between DNase 1-, vincristine sulphate- and P. minima chloroform extract-treated cells to untreated cells (DMSO) at 24 hours treatment
in diﬀerent cell lines. Each value represented mean ± SEM from three independent experiments. ∗P < .001 (as compared with negative
control).
(a) (b)
Figure 3: Trypan blue staining of NCI-H23 cells treated with P. minima chloroform extract (2.80 μg/mL, EC50 at 72 h) post 24 (a) and 72 h
(b) (Original magnification ×200). Necrotic cells were marked by arrow.
results clearly indicated that apoptosis appeared to be
the dominant mechanism of cell death exerted by the
chloroform extract of P. minima in NCI-H23 cells. As for
negative control, the DMSO-treated cells did not show these
morphological characteristics (data not shown).
The existence of apoptotic programed cell death elicited
by chloroform extract of P. minima in NCI-H23 cells
was confirmed using Annexin-V-FLUOS assay (Roche, Ger-
many). The early phase of apoptosis or programed cell death
was evident in most of the cells as shown in Figures 5(a) and
5(b), with weakly scattered fluorescent annexin V (green).
Only a few homogeneous and high intensity annexin V
staining pattern was observed, indicating a later phase of
apoptosis or programed cell death (Figure 5(a)). Meanwhile,
some cells were positively stained with both annexin V and
propidium iodide, which referred to as late stage apoptosis
(secondary necrosis) and programed cell death (Figure 5(b)).
However, the DMSO-treated cells (negative control) did not
exhibit these staining patterns (data not shown). Thus, the
diﬀerent stages of apoptosis or programed cell death were
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Figure 4: Morphological features of apoptosis in NCI-H23 cells after treated with Physalis minima chloroform extract (2.80 μg/mL, EC50
at 72 h) for 24 h. (a) Chromatin clumping (Cclp), chromatin margination (Cmrg), (b) convolution of nuclear membrane (MNcov) and
cytoplasmic outlines (MCcov), (c) budding of cell (MCbud) and led to the formation of apoptotic bodies (AB), were observed (shown by
arrows).
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Figure 5: The eﬀect of P. minima chloroform extract (2.80 μg/mL at 72 h) on NCI-H23 cells for 24 h and subjected to Annex-V-FLUOS kit
(Roche, Germany). A weakly scattered annex in V staining pattern of cell surface was evident in most of the cells (thin arrows). Only a few
of homogenous-high intensity of annex in V fluorescence cells (thick arrow) and both annex in V-propidium iodide stained cells (green and
red fluorescence) (dotted arrows) were also observed.
evident in NCI-H23 cells treated with the chloroform extract
of P. minima.
3.3. Eﬀect of P. minima Chloroform Extract on Apoptosis-
Related Genes Expression Level of NCI-H23 Cells. Semi-
quantitative RT-PCR was used in this study in order to
determine the expression levels of apoptosis-related genes
in P. minima chloroform extract-treated NCl-H23 cells. As
shown in Figures 6(a) and 6(b), the expression of c-myc at
rest (0 h) was not much diﬀerent from stimulated cells at
15 min and 30 min and slightly increased for the next 90 min
before reaching a peak at 3 h (2.1-fold increase). However,
the expression of c-myc was then reduced at 6 h (1.7-fold
increase) and gradually decreased to baseline levels at 18
and 24 h. The mRNA expression of c-myc was statistically
significant at 2, 3 and 6 h post-stimulation as compared to
untreated cells (P < .05) (Figure 6(b)).
As for the caspase-3 gene, the mRNA expression was
induced as early as 15 min and still increased at 30 min
but declined minimally for the next 30 min and gradually
reaching its peak at 3 h with an ∼2.4-fold increase (Figures
6(a) and 6(b)). However, the mRNA expression of caspase-3
was slightly reduced for the next 3 h (2.0-fold increase) and
decreased steadily to the lowest levels at 18 and 24 h time
points. When compared to control cells, the marked increase
of caspase-3 mRNA expression was proven to be statistically
significant from 30 min to 12 h post-stimulation (P < .05)
(Figure 6(b)).
By contrast, the level of p53 mRNA expression was very
low at rest (0 h) but increased dramatically at 15 min and
remained elevated for the next 75 min before reaching the
highest peak at 2 h (2.8-fold increase) (Figures 6(a) and
6(b)). The high mRNA expression of p53 appeared to sustain
until the ninth hour and declined slightly at 12 h and
eventually decreased to the lowest level at 24 h. In addition,
the p53 expression was statistically higher than that control
cells from 15 min to 18 h (P < .05) (Figure 6(b)).
Overall, NCl-H23 cells treated with the chloroform
extract of P. minima exhibited high mRNA expression
levels of c-myc, caspase-3 and p53 within 2–6 h post-
stimulation. Caspase-3 and p53 genes seemed to have similar
expression patterns, whereby their expression was observed
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Figure 6: (a) Time course mRNA expression of β-actin, c-myc,
caspase-3 and p53 in NCI-H23 cells incubated in the absence
or presence of P. minima chloroform extract. β-actin was used
as an internal standard control for each PCR reation. (b) Semi-
quantitative analysis of the c-myc, caspase-3 and p53 mRNA level
in NCI-H23 treated with P. minima chloroform extract using
densitometric scanning. Each value represented mean ± SEM (n =
3 at each point) of the ratio of RT-PCR product of the respective
genes to β-actin, assigning the ratio in unstimulated cells as 1.
∗P < .05 versus C (control).
at early post-stimulation. Moreover, the induction of p53 and
caspase-3 mRNA expression was slightly higher as compared
to that of c-myc gene. Thus, there was a clear indication that
the cell death induced by the chloroform extract of P. minima
in NCl-H23 cells was mediated via the activation of c-myc,
caspase-3 and p53 gene expression.
4. Discussion
It has previously been shown that treatment using P. minima
extracts and compounds inhibited cell proliferation, but the
mechanism of cell death remained unclear [6]. In this study,
we found that the chloroform extract was able to inhibit cell
proliferation and induce apoptosis. These were confirmed by
six independent methods, namely the methylene blue assay
for cytotoxicity evaluation, DeadEnd Colometric System
(Promega, USA) to label the apoptotic nuclei cells, trypan
blue exclusion assay to detect the loss of plasma membrane
integrity of necrotic cell, TEM analysis to describe the
ultrastructural or micro morphology characteristics of the
apoptotic cell, annexin V and propidium iodide staining
to detect the stages of apoptosis and RT-PCR analysis to
determine the mRNA expression level of apoptotic gene.
The extract was found to significantly abrogate the
growth of NCI-H23 cells in a dose- and time-dependent
manner. Based on our chromatographic and spectroscopic
analyses, the extract was found to contain physalins B, F
and K [15]. These isolated physalins which are commonly
found in genus Physalis were reported with a cytotoxic
eﬀect against numerous human cell lines [7, 19, 20]. The
increase in activity of the chloroform extract as compared
with their fractions might be due to the synergistic eﬀect
of the various physalins in the extract. The occurrence of
apoptosis was initially detected based on the percentage of
apoptotic index of the extract-treated NCI-H23 cells that
was significantly higher than that in untreated cells. DNA
fragmentation exhibited in TUNEL assay-labeled nuclei cells
is commonly used as a biochemical index of apoptosis
[21]. Analysis of plasma membrane permeability using the
trypan blue exclusion assay has ruled out necrosis as the
cause of cell death in extract-treated NCI-H23 cells. The
cross-sections of apoptotic cells were also observed using
TEM analysis of the extract-treated NCI-H23 cells. It was
recognized by stereotypical morphological changes such as
shrinking and deformation of cells, blebbing of cytoplasmic
membrane, clumping, condensation and margination of
nuclear chromatin, followed by breaking up of the cells
into small membrane-enclosed apoptotic bodies [22]. The
observation of apoptotic-morphological features was clearly
established in various studies involving anticancer agents
such as cisplatin and flavopiridol that induced apoptosis
in C6 glioma cells [23] and A172 glioma cells, respectively
[24].
The apoptotic programed cell death elicited by the
chloroform extract was also confirmed using the Annexin-
V-FLUOS assay (Roche, Germany). Annexin V is a Ca2+-
dependent phospholipid-binding protein that detects the
phosphatidylserine externalization of the plasma membrane
[25]. With fluorescence microscopy observation, diﬀerent
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Figure 7: An Overview of apoptotic eﬀects elicited by P. minima chloroform extract on NCI-H23 cells. The apoptotic mechanism
was mediated by the activation of p53 (inducer and regulator), caspase-3 (executioner) and c-myc (enhancer dotted lines) which
were reputed as main molecular regulators in both extrinsic and intrinsic pathway. This was subsequently resulting in biochemical
and morphological alterations, including DNA fragmentation; phosphatidylserine (PS) externalization, chromatin migration, membrane
blebbing and apoptotic bodies.
annexin V staining patterns have been observed that indi-
cated diﬀerent phases of apoptosis in the extract-treated cells.
The faintly annexin V-stained cells probably due to a limited
phosphatidylserine exposure during the early stage of apop-
tosis [26, 27]. The heavily stained annexin V and propidium
iodide cells indicated the later phase of the apoptotic process,
whereby the cells lost their plasma membrane integrity and
more binding sites of phosphatidylserine were detected [28].
The roles of c-myc, caspase-3 and p53 mRNA levels
in the chloroform extract-induced apoptotic pathways were
further verified based on their expression profiles at diﬀerent
times of treatment. Both p53 and caspase-3 were significantly
induced by the chloroform extract at the earlier phase of
treatment (15 min and 30 min, resp.). Their expressions were
sustained until the later stages of treatment and the results
provide strong evidences to support the roles of these genes
and their crosstalk in mediating the apoptosis-inducing
eﬀects of the extract. It has been well established that p53-
and caspase-mediated apoptosis of most cells are induced
through the activation of the death receptor (extrinsic) or the
mitochondrial (intrinsic) pathway [29]. Overexpression of
p53 was reported to provoke the extrinsic apoptotic pathway
via the induction of death receptor proteins such as Fas and
TRAIL, which transmitted the apoptotic death signal from
the cell surface to intracellular signaling pathways [30, 31].
The pro-apoptotic function of p53 was also considered to
be associated with the mitochondrial pathway that generally
involves an induction of mitochondrial permeability transi-
tion and the subsequent release of apoptogenic factors such
as cytochrome c that leads to caspase-9 activation, which in
turn cleaves and activates eﬀector caspases such as caspase-3
[32].
p53 was found to be induced 15 min earlier than
caspase-3. This finding suggests that p53 activation may
be an upstream cellular event that leads to mitochondrial
membrane potential disappearance and caspase-3 may be
responsible in executing the downstream process of apop-
tosis that mainly contributed to the typical morphological
changes and DNA fragmentation in apoptotic cells [33].
The activation of caspase-3 has been reported in p53-
induced apoptosis in various systems [34, 35]. Caspase-
3-activated DNase that was induced by Fas-ligand or c-
myc was discovered to be associated with caspase-3 during
apoptosis [36]. The activated DNase was allowed to enter the
nucleus and caused oligonucleosomal DNA fragmentation
[37]. In agreement with this study, the ethanolic extract of
P. peruviana was reported to induce Hep G2 cells apoptosis
through the activation of caspase-3 while the elevation of
p53 expression and caspase-3 activation were observed in
its supercritical carbon dioxide extract-treated H661 cells
[11, 12].
Meanwhile, c-myc gene only demonstrated a transient
mRNA expression (2.1-fold increase) in extract-treated NCI-
H23 cells at 3 h of treatment. The transient increment of this
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gene might enhance the apoptotic eﬀect of p53 and caspase-
3 with marked peak expression of these genes at 2-3 h of
treatment. This is supported by a finding that suggested c-
myc gene as a strong inducer of cell death via induction
of several pro-apoptotic signal transduction mechanisms
[38]. This gene has been described as a repressor to reduce
ubiquitination of p53 that leads to the accumulation of p53
and subsequently triggers caspase-3 [31]. c-myc was reported
to induce apoptosis by destabilizing mitochondrial integrity
[39]. The upregulation of c-myc was essential to enhance the
pro-apoptotic proteins of Bcl-2 family and suppresses their
anti-apoptotic eﬀects [38, 39].
In conclusion, this study could oﬀer scientific basis for
the further in-depth evaluation of the chloroform extract
of P. minima. It inhibited the proliferation of NCI-H23
cells at dose- and time-dependent manner via an apoptotic
programed cell death. The induction of apoptotic cell death
was suggested to be mediated via p53-, caspase-3- and
c-myc-dependent cell apoptotic pathways. Based on the
results obtained in this study, we constructed a mode of
action as depicted in Figure 7. The model proposes that
the chloroform extract induced the expression of p53 that
resulting in the release of apoptogenic factors that would
facilitate the cell apoptosis through the activation of caspase
cascade.
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